US WTO Cases Against China Now Available
On April 10, the US Trade Representative requested consultations with China at the WTO over protection of IP rights and barriers to trade in copyrighted items.
Original news and analysis on international IP policy
On April 10, the US Trade Representative requested consultations with China at the WTO over protection of IP rights and barriers to trade in copyrighted items.
By John T. Aquino for Intellectual Property Watch WASHINGTON, DC – A panel of government representatives from key developing nations this week used the opportunity to highlight efforts at good stewardship of intellectual property rights and acknowledge a link between…
By Tatum Anderson for Intellectual Property Watch A decision on whether the Indian patent law is compliant with World Trade Organisation intellectual property rules could be made sooner than expected, after a dramatic turn of events in the ongoing legal…
By Martin Vaughan for Intellectual Property Watch WASHINGTON, DC – Critics of Thailand’s decision to issue compulsory licenses for several patented drugs said the Thai government violated global trade rules, as they clashed with public health activists at a 16…
By Tove Iren S. Gerhardsen A Thai official says the government’s phones have started ringing a lot more frequently since Thailand issued compulsory licenses to import and eventually produce patented medicines, moving patent owners to drop their prices. But sceptics…
By William New A well-balanced colloquium at the World Intellectual Property Organization allowed views from two sides to be heard on the subject of flexibilities in the patent system. The presenters at the 16 February event appeared to split along…
By Tove Iren S. Gerhardsen One of the companies whose patent may be overruled by Thailand’s issuance of a compulsory license said it was caught off-guard by the Thai move, which was aimed at reducing drug prices. The Thai government…
By Tove Iren S. Gerhardsen As a case challenging India’s patent law proceeds this week, pressure is building from politicians, religious leaders and civil society on Swiss pharmaceutical company Novartis to withdraw the case in the name of public health,…
By Jia Hepeng for Intellectual Property Watch BEIJING – The revision of a long-controversial rule on traditional Chinese medicine (TCM) is stranded amidst heated debates. While the government-led revision committee is analysing its stipulations for future implementation, some experts say…
By Tove Iren S. Gerhardsen After Thailand issued a compulsory license for government production of an HIV/AIDS drug, the patent holder of the product, Merck Sharp & Dohme, has proposed reducing the price by almost two-thirds, local sources said. But…
By Catherine Saez Although China is the biggest traditional knowledge holder in the world and has been patenting its traditional medicine knowledge since 1993, its existing patent regime does not appear to be able to protect traditional knowledge or its…
By Tove Iren S. Gerhardsen Following the rejection of a patent application for one of its medicines, Swiss pharmaceutical company Novartis has taken the “unprecedented action” of challenging India’s patent law in a high court, arguing that it is unconstitutional…